Final answer:
The main cause of β-thalassemia is due to gene mutations leading to aberrant precursor mRNA splicing or premature chain termination during mRNA translation. These mutations decrease the synthesis rate of the beta-globin chain, causing an imbalanced hemoglobin and resulting in anemia.
Step-by-step explanation:
The main cause of β-thalassemia is typically due to gene mutations that affect the transcription, processing, or translation of beta-globin mRNA. These mutations most commonly result in aberrant precursor mRNA splicing or premature chain termination during mRNA translation, causing a decreased synthesis rate of β-chain of globin. This leads to an imbalance in the globin chains that make up hemoglobin, and as a consequence, ineffective erythropoiesis and anemia occur because the red blood cells have less hemoglobin and are less efficient at transporting oxygen.
While gene deletions are typically associated with alpha-thalassemia, β-thalassemia often arises from complex mutations including point mutations that might prevent RNA polymerase from binding to the promoter region, among other potential defects.